VOL. I / NO. 07 / ABOUT THE EDITORS
Does Doctor TB-500 See Patients?
Repair studies tested TB-500 and Thymosin Beta-4. Writers explain those findings here, without offering you a doctor's opinion.
Can You Get a Medical Visit Through These Pages?
Researchers explored TB-500 after studies of the whole Thymosin Beta-4 protein. Animal findings raised hopes for wounds, damaged ligaments, tendons and hearts. Later experiments examined hair roots, injured brains and damaged nerves. Two early trials checked how the whole protein entered and left human blood. Doctor TB-500 explains what those studies found and left unanswered.
The name doesn't mean a doctor sees patients here.
There's no clinic behind these pages, and no doctor or nurse on staff. The writing explains published studies with links to their papers. The team doesn't make, stock or sell any product. These explanations aren't personal medical advice for your own illness.
You cannot receive a visit, prescription or treatment through this site.
Nobody here examines your knee or checks your other medicines. An animal injury cannot establish the right care for your injury. Study findings explain research, but don't settle a personal treatment choice. Your own health history belongs in a discussion with your doctor.
Do Approval or Sport Rules Prove TB-500 Works?
The FDA hasn't approved TB-500 for treating people. Whole Thymosin Beta-4 has had early human safety tests. A Phase 2 trial tested dry-eye treatment, an early patient test of benefit and harm. As of 2025, no FDA approval covered whole-body Thymosin Beta-4 treatment. TB-500 had no approval for any illness either.
Encouraging tests don't give permission to promise a treatment result.
WADA sets world drug rules in sport and bans TB-500 at all times. Competitions and the time between competitions are both covered. The banned groups include peptides, growth substances and unapproved substances. Breaking the rule can mean up to four years away from sport. At least one athlete received a Canadian Centre for Ethics in Sport sanction. That athlete's sanction involved TB-500.
TB-500 isn't a controlled substance under US drug law.
Legal restrictions and medicine approval answer different questions. Neither this drug status nor a sport ban proves your treatment would work. Research still needs to establish benefit and safety in people.

Whose Opinion Are You Reading Here?
Editors write these explanations; a doctor doesn't write or review them. Published papers and reviews provide the findings, with numbered links to the originals. Sources include PubMed, PubMed Central and ClinicalTrials.gov, which list medical research. Your own doctor can discuss those findings alongside your health history.
A study explanation isn't a medical opinion about your illness.
A review gathers findings from several studies without treating new patients. Other researchers check published reviews, but that doesn't prove every proposed treatment. Most repair findings here concern animals and leave human questions unanswered. Early Thymosin Beta-4 trials checked harm in healthy volunteers. A Phase 2 dry-eye trial was an early test of benefit and harm in patients with one eye illness. Those tests didn't establish how to repair your injured knee. TB-500 with BPC-157 still lacks a published trial comparing treatment groups.
Questions about these explanations can reach the writers through /contact.